Trends and disparities in type 1 diabetes–related mortality in the United States, 1999–2023

Diabetes Obesity and Metabolism 2026 Open access

Read full text
Authors: Kaixin Yao, Xichen Yang, Shuhui Lei, Shuwen Yin, Zhongyan Xu
DOI: 10.1111/dom.70546
Cited by: 0
References: 5

Abstract

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by pancreatic β-cell destruction and lifelong insulin dependence. 1 Although therapeutic advances-including insulin analogs and continuous glucose monitoring (CGM)-have improved glycaemic management, individuals with T1DM continue to face elevated risks of acute metabolic crises and long-term complications.2,3 Given these persistent challenges, this study examines trends in T1DM-related mortality among U.S. adults from 1999 to 2023 to inform equitable prevention and management strategies.

Fields of Study & Subjects

Diabetes Management and Research Diabetes Management and Education Diabetes and associated disorders

Publication details

Journal / source
Diabetes Obesity and Metabolism
Volume
28
Issue
5
Pages
4356–4360
Publication date
12 February 2026
Language
EN